Rossmore Private Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.8M | Sell |
4,446
-206
| -4% | -$83.5K | 0.21% | 86 |
|
2025
Q1 | $2.31M | Buy |
4,652
+24
| +0.5% | +$11.9K | 0.29% | 69 |
|
2024
Q4 | $2.39M | Sell |
4,628
-20
| -0.4% | -$10.3K | 0.3% | 70 |
|
2024
Q3 | $2.88M | Sell |
4,648
-6
| -0.1% | -$3.71K | 0.36% | 59 |
|
2024
Q2 | $2.57M | Sell |
4,654
-12
| -0.3% | -$6.64K | 0.34% | 62 |
|
2024
Q1 | $2.71M | Sell |
4,666
-28
| -0.6% | -$16.3K | 0.35% | 63 |
|
2023
Q4 | $2.49M | Sell |
4,694
-1
| -0% | -$531 | 0.35% | 64 |
|
2023
Q3 | $2.38M | Sell |
4,695
-21
| -0.4% | -$10.6K | 0.36% | 59 |
|
2023
Q2 | $2.46M | Sell |
4,716
-63
| -1% | -$32.9K | 0.37% | 59 |
|
2023
Q1 | $2.75M | Sell |
4,779
-240
| -5% | -$138K | 0.43% | 56 |
|
2022
Q4 | $2.76M | Sell |
5,019
-222
| -4% | -$122K | 0.44% | 57 |
|
2022
Q3 | $2.66M | Buy |
5,241
+22
| +0.4% | +$11.2K | 0.48% | 51 |
|
2022
Q2 | $2.84M | Buy |
5,219
+6
| +0.1% | +$3.26K | 0.49% | 51 |
|
2022
Q1 | $3.08M | Hold |
5,213
| – | – | 0.48% | 56 |
|
2021
Q4 | $3.48M | Buy |
5,213
+144
| +3% | +$96.1K | 0.54% | 51 |
|
2021
Q3 | $2.9M | Sell |
5,069
-1
| -0% | -$571 | 0.5% | 53 |
|
2021
Q2 | $2.56M | Sell |
5,070
-52
| -1% | -$26.2K | 0.44% | 57 |
|
2021
Q1 | $2.34M | Buy |
5,122
+284
| +6% | +$130K | 0.44% | 59 |
|
2020
Q4 | $2.25M | Sell |
4,838
-112
| -2% | -$52.2K | 0.46% | 58 |
|
2020
Q3 | $2.19M | Buy |
4,950
+355
| +8% | +$157K | 0.51% | 52 |
|
2020
Q2 | $1.67M | Buy |
4,595
+2,129
| +86% | +$771K | 0.46% | 57 |
|
2020
Q1 | $699K | Buy |
+2,466
| New | +$699K | 0.24% | 89 |
|
2018
Q1 | – | Sell |
-173
| Closed | -$32.8K | – | 375 |
|
2017
Q4 | $32.8K | Buy |
+173
| New | +$32.8K | 0.03% | 201 |
|